Tag: ofatumumab

#VisualAbstract: Ofatumumab vs. teriflunomide for multiple sclerosis

byConstance Wu

August 18, 2020

1. In this double-blind, randomized phase 3 trial, patient treated with ofatumumab had a lower annualized relapse rate in multiple ...

Ofatumumab may reduce annual relapse rates compared to teriflunomide in multiple sclerosis

bySze Wah Samuel Chanand1 others

August 10, 2020

1. In this double-blind, randomized phase 3 trial, patient treated with ofatumumab had a lower annualized relapse rate in multiple ...

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result

Tag: ofatumumab

#VisualAbstract: Ofatumumab vs. teriflunomide for multiple sclerosis

Ofatumumab may reduce annual relapse rates compared to teriflunomide in multiple sclerosis

2MM+ All Access

Recent Reports

The medical literature, distilled daily.

Membership benefits